Goldman Sachs Group Inc Inovio Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.35 - $0.53 $12,655 - $19,164	-36,159 Reduced 50.78%	35,042 $17,000
Q3 2023 May 14, 2024	BUY	$0.38 - $0.58 $13,740 - $20,972	36,159 Added 103.19%	71,201 $27,000
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $79,711 - $121,664	-209,767 Reduced 74.66%	71,201 $27,000
Q2 2023 May 14, 2024	SELL	$0.39 - $0.94 $608,488 - $1.47 Million	-1,560,227 Reduced 84.74%	280,968 $126,000
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.94 $608,488 - $1.47 Million	-1,560,227 Reduced 84.74%	280,968 $126,000
Q1 2023 May 14, 2024	BUY	$0.79 - $1.91 $82,716 - $199,984	104,704 Added 6.03%	1,841,195 $1.51 Million
Q1 2023 May 11, 2023	BUY	$0.79 - $1.91 $82,716 - $199,984	104,704 Added 6.03%	1,841,195 $1.51 Million
Q4 2022 May 14, 2024	SELL	$1.41 - $2.5 $759,107 - $1.35 Million	-538,374 Reduced 23.67%	1,736,491 $2.71 Million
Q4 2022 Feb 13, 2023	SELL	$1.41 - $2.5 $759,107 - $1.35 Million	-538,374 Reduced 23.67%	1,736,491 $2.71 Million
Q3 2022 May 14, 2024	BUY	$1.66 - $2.79 $1.3 Million - $2.19 Million	785,998 Added 52.79%	2,274,865 $3.92 Million
Q3 2022 Nov 10, 2022	BUY	$1.66 - $2.79 $1.3 Million - $2.19 Million	785,998 Added 52.79%	2,274,865 $3.94 Million
Q2 2022 May 14, 2024	BUY	$1.44 - $3.98 $2.09 Million - $5.79 Million	1,453,825 Added 4148.81%	1,488,867 $2.58 Million
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $800,045 - $2.21 Million	555,587 Added 59.53%	1,488,867 $2.58 Million
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $2.35 Million - $4.12 Million	-792,044 Reduced 45.91%	933,280 $3.35 Million
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $156,057 - $233,304	-31,274 Reduced 1.78%	1,725,324 $8.61 Million
Q3 2021 Nov 10, 2021	BUY	$7.16 - $9.69 $12.6 Million - $17 Million	1,756,598 New	1,756,598 $12.6 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $544M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account